$3.07 Billion is the total value of Artal Group S.A.'s 81 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PEP | New | PEPSICO INCcall | $23,850,000 | – | 300,000 | +100.0% | 0.78% | – |
| M | New | MACYS INCcall | $23,799,000 | – | 550,000 | +100.0% | 0.78% | – |
| RLGY | New | REALOGY HLDGS CORPcall | $15,057,000 | – | 350,000 | +100.0% | 0.49% | – |
| ITB | New | ISHARES INCcall | $11,170,000 | – | 500,000 | +100.0% | 0.36% | – |
| GM | New | GENERAL MTRS COcall | $10,791,000 | – | 300,000 | +100.0% | 0.35% | – |
| ESV | New | ENSCO PLCcall | $10,750,000 | – | 200,000 | +100.0% | 0.35% | – |
| TEX | New | TEREX CORP NEW | $9,240,000 | – | 275,000 | +100.0% | 0.30% | – |
| RLGY | New | REALOGY HLDGS CORP | $8,604,000 | – | 200,000 | +100.0% | 0.28% | – |
| UAL | New | UNITED CONTL HLDGS INC | $7,678,000 | – | 250,000 | +100.0% | 0.25% | – |
| GS | New | GOLDMAN SACHS GROUP INC | $6,328,000 | – | 40,000 | +100.0% | 0.21% | – |
| MDLZ | New | MONDELEZ INTL INCcall | $6,284,000 | – | 200,000 | +100.0% | 0.20% | – |
| MTOR | New | MERITOR INC | $5,896,000 | – | 750,100 | +100.0% | 0.19% | – |
| MAS | New | MASCO CORPcall | $5,320,000 | – | 250,000 | +100.0% | 0.17% | – |
| SPHS | New | SOPHIRIS BIO INC | $4,680,000 | – | 1,000,000 | +100.0% | 0.15% | – |
| PHM | New | PULTE GROUP INCcall | $4,125,000 | – | 250,000 | +100.0% | 0.13% | – |
| BLUE | New | BLUEBIRD BIO INC | $4,044,000 | – | 150,000 | +100.0% | 0.13% | – |
| QCOM | New | QUALCOMM INC | $3,366,000 | – | 50,000 | +100.0% | 0.11% | – |
| LEG | New | LEGGETT & PLATT INCcall | $3,015,000 | – | 100,000 | +100.0% | 0.10% | – |
| MS | New | MORGAN STANLEY | $2,695,000 | – | 100,000 | +100.0% | 0.09% | – |
| SUNEQ | New | SUNEDISON INC | $1,993,000 | – | 250,000 | +100.0% | 0.06% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $1,957,000 | – | 70,000 | +100.0% | 0.06% | – |
| LEN | New | LENNAR CORPcl a | $1,770,000 | – | 50,000 | +100.0% | 0.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-05-17 |
| 4 | 2024-05-14 |
| 13F-HR | 2024-05-13 |
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.